JPRN-jRCT1080220722未知4 期
Post-marketing Clinical Study of Irbesartan <Evaluation of safety and efficacy of long-term administration>
适应症
试验速览
- 阶段
- 4 期
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 25age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •Patients whose trough seated blood pressure at the end of washout period >= 160/90 mmHg or >= 150/95 mmHg
排除标准
- •Patients with renal, hepatic or heart disease
研究者
相似试验
已完成
4 期
Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical PracticeHypertensionNCT00564187Sanofi115
已完成
4 期
Effects of the combination therapy of irbesartan and indapamide in chronik kidney disease with hypertensiochronick kidney disease with hypertensionJPRN-UMIN000010787Division of Nephrology, Department of Internal medicine, Jichi Medical University30
招募中
不适用
Effect of on combination therapy with irbesartan and amlodipine besilate on clinical blood pressure, home blood pressure and blood pressure variability in hypertensive patients with chronic kidney diseaseHypertension with chronic kidney disease (CKD G1-G4)JPRN-UMIN000013213Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine30
已完成
不适用
Feasible study of the effect of irbesartan on psoriasispsoriasisJPRN-UMIN000025949Department of Dermatology, Kochi Medical School, Kochi University10
已完成
不适用
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy I-COMBINEPER-008-09sanofi-aventis Recherche & Development,